K E Stein

1.6k total citations
28 papers, 1.2k citations indexed

About

K E Stein is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, K E Stein has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 15 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in K E Stein's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (10 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). K E Stein is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (10 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). K E Stein collaborates with scholars based in United States, Sweden and Thailand. K E Stein's co-authors include T. Söderstrom, W E Paul, Patricia K. A. Mongini, Leonard J. Rubinstein, Joseph M. Davie, J J Mond, Roger M. Perlmutter, J H Slack, Ian M. Zitron and Moon H. Nahm and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

K E Stein

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K E Stein United States 18 633 401 373 332 252 28 1.2k
Noelene E. Byars United States 18 569 0.9× 248 0.6× 223 0.6× 414 1.2× 84 0.3× 27 1.2k
Chantal Tougne Switzerland 21 1.0k 1.6× 427 1.1× 153 0.4× 305 0.9× 110 0.4× 31 1.7k
Percy Minden United States 20 400 0.6× 363 0.9× 257 0.7× 245 0.7× 130 0.5× 60 1.2k
Susanne Hausmann Germany 5 1.4k 2.2× 260 0.6× 155 0.4× 453 1.4× 225 0.9× 6 1.8k
R SMITH United Kingdom 13 359 0.6× 195 0.5× 184 0.5× 378 1.1× 69 0.3× 18 1.2k
B. Mansa Denmark 18 238 0.4× 155 0.4× 161 0.4× 312 0.9× 143 0.6× 53 935
L. Pyhälä Finland 14 454 0.7× 287 0.7× 92 0.2× 252 0.8× 183 0.7× 26 1.1k
Morten Simonsen Denmark 25 834 1.3× 161 0.4× 195 0.5× 269 0.8× 130 0.5× 53 1.5k
René Pirès France 13 297 0.5× 182 0.5× 165 0.4× 119 0.4× 159 0.6× 18 626
Guy T. Layton United Kingdom 22 794 1.3× 321 0.8× 173 0.5× 561 1.7× 35 0.1× 50 1.7k

Countries citing papers authored by K E Stein

Since Specialization
Citations

This map shows the geographic impact of K E Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K E Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K E Stein more than expected).

Fields of papers citing papers by K E Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K E Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K E Stein. The network helps show where K E Stein may publish in the future.

Co-authorship network of co-authors of K E Stein

This figure shows the co-authorship network connecting the top 25 collaborators of K E Stein. A scholar is included among the top collaborators of K E Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K E Stein. K E Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stein, K E. (2002). Immunogenicity: concepts/issues/concerns.. PubMed. 109. 15–23. 9 indexed citations
2.
Brorson, Kurt, et al.. (2001). Use of a Quantitative Product-Enhanced Reverse Transcriptase Assay to Monitor Retrovirus Levels in mAb Cell-Culture and Downstream Processing. Biotechnology Progress. 17(1). 188–196. 24 indexed citations
3.
Stein, K E, et al.. (1999). Determination of the IgG2a allotype of CXB recombinant inbred mouse strains by a PCR-based method. Immunogenetics. 50(1-2). 71–73. 2 indexed citations
4.
Brorson, Kurt, Mark Brunswick, Sergei A. Ezhevsky, et al.. (1997). xid affects events leading to B cell cycle entry. The Journal of Immunology. 159(1). 135–143. 55 indexed citations
5.
Boswell, Christopher M. & K E Stein. (1996). Avidity maturation, repertoire shift, and strain differences in antibodies to bacterial levan, a type 2 thymus-independent polysaccharide antigen. The Journal of Immunology. 157(5). 1996–2005. 17 indexed citations
6.
Stein, K E. (1992). Thymus-Independent and Thymus-Dependent Responses to Polysaccharide Antigens. The Journal of Infectious Diseases. 165(Supplement 1). S49–S52. 292 indexed citations
7.
Boswell, Christopher M., Diana Irwin, Joanne Goodnight, & K E Stein. (1992). Strain-dependent restricted VH and VL usage by anti-bacterial levan monoclonal antibodies. The Journal of Immunology. 148(12). 3864–3872. 12 indexed citations
8.
Rubinstein, Leonard J., et al.. (1991). A simple method for coating native polysaccharides onto nitrocellulose. Journal of Immunological Methods. 137(2). 261–266. 5 indexed citations
9.
Stein, K E, et al.. (1991). VH gene family expression in mice with the xid defect.. The Journal of Experimental Medicine. 174(1). 45–51. 10 indexed citations
10.
Söderstrom, T., Lars Hanson, Lena Öhman, et al.. (1985). Studies on immunity against escherichia coli K13 with monoclonal Anti-K13 and Anti-anti-K13. Infection. 13(S2). S256–S259. 1 indexed citations
11.
Stein, K E. (1985). Network Regulation of the Immune Response to Bacterial Polysaccharide Antigens. Current topics in microbiology and immunology. 119. 57–74. 26 indexed citations
12.
Stein, K E & T. Söderstrom. (1984). Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.. The Journal of Experimental Medicine. 160(4). 1001–1011. 209 indexed citations
14.
Stein, K E, David A. Zopf, Carole B. Miller, et al.. (1983). Immune response to a thymus-dependent form of B512 dextran requires the presence of Lyb-5+ lymphocytes.. The Journal of Experimental Medicine. 157(2). 657–666. 28 indexed citations
15.
Söderstrom, T., K E Stein, Charles C. Brinton, et al.. (1982). Serological and Functional Properties of Monoclonal Antibodies to <i>Escherichia coli</i> Type I Pilus and Capsular Antigens. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 33. 259–274. 19 indexed citations
16.
Mongini, Patricia K. A., K E Stein, & W E Paul. (1981). T cell regulation of IgG subclass antibody production in response to T-independent antigens.. The Journal of Experimental Medicine. 153(1). 1–12. 144 indexed citations
17.
Woods, V L, et al.. (1980). Augmentation of in vitro humoral immune responses in the mouse by an antibody to IgD.. The Journal of Experimental Medicine. 152(3). 493–506. 13 indexed citations
18.
Bona, C, Patricia K. A. Mongini, K E Stein, & W E Paul. (1980). Anti-immunoglobulin antibodies. I. Expression of cross-reactive idiotypes and Ir gene control of the response to IgG2a of the b allotype.. The Journal of Experimental Medicine. 151(6). 1334–1348. 24 indexed citations
19.
Stein, K E, et al.. (1980). Regulation of the anti-inulin antibody response by a nonallotype-linked gene.. The Journal of Experimental Medicine. 151(5). 1088–1102. 28 indexed citations
20.
Perlmutter, Roger M., Moon H. Nahm, K E Stein, et al.. (1979). Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect.. The Journal of Experimental Medicine. 149(4). 993–998. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026